A new breakout can make it tempting to change several things at once: wash more often, cut out foods, or add another product. Then it becomes difficult to tell what helped and what irritated your skin. To build a sustainable routine, consider focusing on one change at a time. For example, start by introducing a single new product, such as a gentle cleanser, and keep the rest of your routine the same for a few weeks. This approach allows you to observe your skin’s response and understand what makes a difference. A sustainable routine starts with organizing those decisions and allowing enough time.
Acne vulgaris is among the world’s most common skin conditions. A 2020 review in Scientific Reports cited a global estimate of roughly 9.4% across all ages, based on the 2010 Global Burden of Disease study. That is a historical estimate; figures vary with age, population, and the definition of acne.
Its familiarity can obscure its impact. Beyond the physical symptoms, acne can take an emotional toll, affecting confidence and well-being. It is normal to feel frustrated, self-conscious, or even discouraged, and these feelings are valid and deserving of support. Acne may affect how someone feels about a photograph, a conversation, or a social event. A practical approach rests on four pillars: gentle cleansing, topical treatment, modifiable habits, and follow-up with a simple diary.
The essentials in 30 seconds
- Acne can affect self-esteem and social life, and deserves care.
- Start with gentle cleansing and evidence-based topical treatments such as adapalene and benzoyl peroxide.
- A diary can track treatment and possible triggers, making it easier to see what changes may help or cause irritation. Each day, you might jot down which products you used, any changes you noticed in your skin, and how you felt—such as dryness, breakouts, or mood. This record helps you look back and review your response after 8–12 weeks.
- Milk and dietary glycemic load are linked in some studies, but evidence does not support restricting foods for everyone.
- Painful nodules, scarring, or emotional distress are reasons to seek care sooner.
Acne also affects how you feel.
A systematic review in the 2026 volume of the American Journal of Clinical Dermatology brought together 101 studies on quality of life and psychosocial well-being. It documented effects on self-esteem, relationships, and mental health, although methods and impact size varied substantially.
A useful appointment should address both your skin and what acne is doing to your life. Avoiding social events, persistent embarrassment, or feeling sad about acne are valid reasons to ask for help. Your family physician or another primary care clinician can begin that conversation and coordinate dermatology care when needed. Support can also come from other sources. Many people find it helpful to connect with counseling services, mental health professionals, or peer support groups—either in person or through online communities focused on skin health and well-being. These resources can offer understanding, coping strategies, and a place to share experiences.
Acne develops within the hair follicle, involving blockage, oil production, inflammation, and the bacterium Cutibacterium acnes. Hormones and family history also play a role. Understanding this can remove an unnecessary burden: acne does not establish that someone is unhygienic or undisciplined.
Pillar one: cleanse gently
A mild cleanser, lukewarm water, and your fingertips are usually enough. Pat your skin dry. A fragrance-free moisturizer and products labeled “noncomedogenic” may help keep the routine tolerable.
Washing morning and evening is a reasonable starting point, adjusted for skin sensitivity. Direct evidence is limited: a small trial of face-washing frequency found improvements within the twice-daily group but no statistically significant differences between groups. It does not establish that more washing clears acne.
Abrasive scrubs, sponges, and drying toners can add irritation. One practical purpose of cleansing is to help your skin tolerate the treatment with stronger evidence behind it.
Pillar two: choose a treatment and learn to use it
The American Academy of Dermatology (AAD) 2024 guideline recommends topical retinoids and benzoyl peroxide, and supports combining mechanisms of action when appropriate. Both have stronger evidence for treating acne than dietary interventions.
Adapalene 0.1% is a retinoid that helps keep pores clear and prevent new lesions. Apply a thin layer across the acne-prone area, following the package directions. It helps prevent pimples before they become visible. In the United States, the gel is available over the counter for people ages 12 and older.
Benzoyl peroxide comes in several strengths and formulations and acts against C. acnes. No resistance to benzoyl peroxide has been reported. It can irritate skin and bleach fabrics; lower concentrations may be easier to tolerate. If you choose a wash containing it, follow that product’s contact-time instructions.
Combining adapalene 0.1% with benzoyl peroxide 2.5% can be more effective than either ingredient alone. In one trialdescribed in the prescribing information, about 30 out of 100 participants achieved clear or almost-clear skin and a two-grade improvement on the investigator’s scale at 12 weeks, compared with 11 out of 100 using the gel without active ingredients. Most had moderate acne. Improvement is also possible without meeting that strict endpoint.
A morning and evening routine
This example provides a starting point for mild acne in adolescents ages 12 and older and adults. For moderate acne, it can form part of a plan developed with a healthcare professional.
| Morning | Gentle cleansing → moisturizer → broad-spectrum sunscreen. | Choose products your skin tolerates, preferably labeled noncomedogenic. |
| Morning, if your plan includes separate benzoyl peroxide | Use it after cleansing, before finishing your skin care. | Follow the label: some formulations rinse off and others stay on. |
| Evening | Gentle cleansing → let skin dry → adapalene or the selected combination → moisturizer. | Apply a thin layer over the acne-prone area, avoiding eyes, lips, and damaged skin. |
If your product already combines both ingredients, avoid adding another dose of the same active ingredient. Over-the-counter availability depends on the country and formulation.
Irritation calls for adjustments.
Dryness, redness, and peeling can develop early in treatment. These are among the most common side effects of topical acne therapy. Guidelines allow reducing application frequency and using moisturizer to improve tolerance. To help manage dryness or irritation, choose a gentle, fragrance-free moisturizer labeled as noncomedogenic. Applying moisturizer after washing and again after the treatment has absorbed can reduce irritation. Avoid harsh or alcohol-based products. If your skin becomes very dry or irritated, consider pausing the treatment for a day or two, and reintroduce it less frequently. Starting on alternate evenings may help; increase frequency according to your skin’s response and the product or clinician’s instructions.
Applying more will not improve it faster. If irritation is severe, worsening, or persistent, pause the product and ask for advice. Stop using it and seek care for hives or swelling; trouble breathing or swelling of the tongue or throat requires emergency care.
If you are pregnant or planning pregnancy, do not start adapalene on your own; ask about an alternative. If you become pregnant while using it, stop and contact your clinician. Review treatment during breastfeeding as well. This routine is not a self-treatment guide for children younger than 12.
Extensive or painful acne, or acne that is leaving scars, calls for a prescription-treatment assessment. The accompanying appointment guide explains oral options and how to monitor them.
Pillar three: give diet a proportionate role
Diet is a legitimate question. The most studied links include high-glycemic-load eating patterns and milk consumption, particularly skim milk. Observing more acne among people who consume a food is different from showing that removing it improves acne.
Glycemic load considers both how quickly a food raises blood glucose and how much carbohydrate is in a serving. Proposed acne mechanisms involve insulin and insulin-like growth factor 1 signaling. A plausible biological explanation does not guarantee a clinical benefit.
In a 12-week trial involving 43 males ages 15–25, a low-glycemic-load diet reduced lesions more than the comparison diet. That group also lost more weight, making it difficult to separate the effects. The AAD guideline includes other favorable findings but also an 84-person trial in which adding a low-glycemic diet to benzoyl peroxide did not significantly improve lesion counts.
The AAD therefore considers the evidence on low-glycemic-load diets conflicting and insufficient to recommend reducing dairy or whey, or using omega-3 fatty acids, as acne treatments.
| Lower glycemic load | Small favorable trials exist alongside inconsistent findings. | You might replace a sugary drink with water or include beans and whole grains. There is no need to remove all carbohydrates. |
| Less milk, particularly skim milk | The association comes mainly from observational research; it does not establish that removing milk treats acne. | If you drink it regularly and want to explore a connection, agree on one change and a nutritionally adequate replacement. This does not require eliminating all dairy. |
| Review whey protein | Evidence linking it with breakouts is limited. | Note whether starting it coincided with new or worsening acne, and discuss it at an appointment. |
| Mediterranean-style eating, vegetables, and fish | Biological plausibility and preliminary findings exist; firm evidence of acne-specific efficacy is lacking. | These can be part of a varied diet. Current findings do not establish omega-3 supplements as an acne treatment. |
Choices should fit your budget, food culture, and nutritional needs. Adolescents should avoid broad restrictions without guidance. An increasingly limited diet may become a burden without a demonstrated improvement.
Sleep, stress, and movement without blame
A 2026 cross-sectional study of nearly 12,000 adults in southern China linked later sleep and greater sedentary time with more acne, and regular exercise with less. Its design cannot show that changing those behaviors clears acne. Stress research also describes associations, and the relationship can run both ways.
Regular sleep schedules, time for movement, and support when stress feels heavy are ways to care for your well-being. They do not make every breakout a consequence of a poor night’s sleep. Daily skin care also includes avoiding squeezing lesions and reviewing repeated friction from sports equipment or greasy products that contact the face.
Pillar four: use a diary to care with intention
As a physician, I believe in the power of intention. With acne care, that can mean deciding which change you will maintain, what you will observe, and when you will assess the result. A diary turns those decisions into information you can review and bring to an appointment.
It may help you recognize possible triggers and record what coincides with improvement or worsening. It also helps you describe how much your skin changed and whether the plan fits your life. Recording treatment use alongside the exposures you are exploring makes it more useful.
Improvement may begin around week 6, although some people need longer. An 8–12-week review helps assess tolerance, consistency, and response; benefits can keep increasing over the following months. Switching products every few days makes that assessment harder.
That timeframe guides review of the initial routine. If you take an oral medication, follow its specific appointment and testing schedule, which may require earlier checks.
| Starting point | Products and strengths; a photo if helpful. | Establish a comparison. |
| First 2–4 weeks | Dryness, burning, and application days. | Address tolerance without increasing the amount. |
| Around week 6 | The trend in new lesions and how manageable the routine feels. | Review barriers and expectations. |
| Weeks 8–12 | Overall improvement, adverse effects, scarring, and emotional well-being. | Continue or adjust the plan; seek care if the response is insufficient. |
A 2019 trial found better outcomes with illustrated instructions and text reminders among people using a combination treatment. That finding supports helping people maintain their plan. The diary proposed here is a practical personal observation tool, rather than a validated test for confirming causes.
What to record and how to measure change
Each day, note whether you applied treatment, how well you tolerated it, and the single habit or product you are exploring. If doxycycline was prescribed, record the dose and starting date, then log each dose and time. If tracking milk, note the type and amount; if you notice a menstrual pattern, record the cycle day. You don’t need to monitor every food or activity.
You can repeat this table each week. For irritation: 0 = none, 1 = mild, 2 = moderate, 3 = severe. These are practical categories, not a validated diagnostic scale.
| Monday | |||
| Tuesday | |||
| Wednesday | |||
| Thursday | |||
| Friday | |||
| Saturday | |||
| Sunday |
Once a week, count red or pus-filled pimples in the same area, total the treatment days, and note how much acne affects your life. If photos help, use similar lighting and framing. If counting or photographing increases your worry, record a simple trend instead: better, the same, or worse.
Hypothetical example: going from 20 inflammatory lesions to 12 means 8 fewer lesions, a 40% reduction. That describes the change you observed during that period. Your diary should also capture whether improvement came with irritation or a routine that was difficult to maintain.
When exploring a dietary change, keeping other parts of your routine as stable as possible makes trends easier to interpret. Record any treatment changes as well: their effects and natural acne fluctuations may explain part of an improvement. The cited dietary trials generally lasted about 8–12 weeks; a 4–6-week window has not been validated for confirming triggers. Repeated patterns can help you ask better questions, without drawing conclusions from yesterday’s food or continuing restrictions without a clear benefit.
What to do this week and when to seek care
First, simplify. List your products’ active ingredients and check for duplication. Second, prepare the routine. Choose manageable times and ask for guidance if you are unsure about selection or tolerance. Third, schedule a review. Set a date 8–12 weeks away, and track both your skin and acne’s effect on your life.
Seek care sooner if you notice any of the following: deep, painful bumps under the skin; rapid worsening or large areas of acne; new or worsening scarring; or significant emotional distress related to your skin. Sudden onset of acne, or acne that appears together with irregular periods or excess hair growth, also deserves prompt evaluation. Additional signs that call for urgent medical attention include painful, swollen skin; signs of infection such as warmth or pus; fever; or severe facial swelling. If you experience difficulty breathing or swelling of the tongue or throat, seek emergency care. Finally, if you don’t improve after about 12 weeks of consistent, appropriate treatment, review the diagnosis and treatment plan with a healthcare professional.
Prescription options include hormonal therapies for selected patients and other treatments for more severe disease. Once acne improves, you may need maintenance; discuss that at follow-up.
The aim is to make skin care a manageable part of your life. Knowing what to use, what to expect, and when to ask for help leaves less energy tied up in every new piece of advice and more for the activities you want to return to.
Appointment guide: prescription treatments
When doxycycline may be added
For moderate-to-severe inflammatory acne with numerous red or pus-filled lesions, a clinician may add oral doxycycline. The AAD gives it a strong recommendation based on moderate-certainty evidence. It can help control inflammation for a limited period while topical treatment remains part of the plan and provides a basis for maintenance.
Do not use doxycycline alone for acne. Pair it with benzoyl peroxide and other topicals, usually a retinoid, to improve control and limit antibiotic resistance. Use should be as brief as possible, generally no longer than 3–4 months, with a response review and a plan for ongoing topical care. Longer courses need a reason and reassessment.
The European EuroGuiDerm update published in 2026 generally limits systemic antibiotics to 3 months, unless clinical circumstances justify extending treatment.
Clinicians choose the dose at an appointment. Studied regimens include conventional doses such as 100 mg daily and lower doses such as modified-release 40 mg daily. A 662-participant trial found comparable results for some outcomes and better tolerance with the 40 mg formulation. Still, the AAD considers the overall direct-comparison evidence insufficient to establish a preferred dose for everyone. Formulations should not be exchanged on your own.
| Taking it | Follow the prescription, take it with plenty of water, remain upright for at least 30 minutes, and avoid taking it just before bed. |
| Sun and skin | Use sun protection. Doxycycline can increase sun sensitivity; seek advice for a substantial reaction. |
| Food, milk, and supplements | Instructions depend on the formulation. Some labels allow food or milk for stomach irritation. Separate antacids or iron, calcium, and magnesium preparations as directed by your pharmacist. |
| Pregnancy and breastfeeding | Other options are chosen for acne during pregnancy. If breastfeeding, review an alternative before starting a course lasting months. |
| Follow-up | Record the dose, planned review date, and daily use. Do not combine it with oral isotretinoin. |
Doxycycline labeling warns about digestive effects, esophageal injury, and sun sensitivity. Seek prompt care for painful swallowing, severe or persistent diarrhea, or a severe headache with visual changes. Nodules, scarring, or an insufficient response call for reassessing options instead of automatically extending the antibiotic course.
When to consider isotretinoin
Oral isotretinoin can produce lasting remission. The AAD supports considering it for severe acne, failure of standard treatments, scarring, or substantial psychosocial burden. The EuroGuiDerm update published in 2026 strongly recommends it for severe papulopustular or moderate nodular acne, and for severe nodular or conglobate acne. These situations can warrant a direct assessment for isotretinoin, depending on the circumstances and local requirements.
Distinguish that clinical recommendation from the U.S. label indication: severe nodular acne resistant to conventional therapy in people ages 12 and older. Selection requires an experienced prescriber and follow-up. It involves revising the treatment plan, including topicals, to avoid unnecessary irritation.
Daily dose and cumulative dose are different decisions. Daily dose is what you take each day; cumulative dose is the total course relative to body weight. The prescriber adjusts them based on severity, response, tolerance, and formulation.
| EuroGuiDerm 2026: severe papulopustular or moderate nodular acne | A daily dose of 0.3–0.5 mg/kg can be recommended. |
| EuroGuiDerm 2026: severe nodular or conglobate acne | At least 0.5 mg/kg daily can be recommended; an increase up to 1 mg/kg daily can be considered for an inadequate response. |
| Duration in EuroGuiDerm | At least 6 months, extending if needed. Based on clinical experience, the group also generally seeks 1–2 months without inflammatory lesions, depending on severity. |
| U.S. label for one conventional formulation | Describes 0.5–1 mg/kg daily in 2 divided doses for 15–20 weeks. Food and dosing instructions must match the prescribed product. |
These regimens come from different sources and are not choices to calculate or select on your own. The European recommendation combines evidence and consensus. The traditional cumulative target of 120–150 mg/kg is a historical reference, but EuroGuiDerm does not establish an evidence-based cumulative dose that guarantees preventing relapse or another course.
A 2025 JAMA Dermatology cohort of 19,907 people, followed for an average of about 25 months, found that 22.5% later received another systemic treatment for relapse and 8.2% repeated isotretinoin. Higher cumulative doses were associated with less relapse, but the study was observational and estimated patient weights. A cumulative number cannot become an individual guarantee.
Laboratory monitoring depends on risk. Clinicians review lipids and liver function before treatment. For healthy patients, a 2022 international consensus proposed checking alanine aminotransferase, a liver enzyme, and triglycerides before starting and at peak dose, without automatic monthly panels. The AAD does not consider routine complete blood counts necessary in healthy patients. Preexisting abnormalities and other risks may require additional checks; pregnancy testing has its own required schedule.
Pregnancy requires strict prevention. Isotretinoin can cause serious congenital disabilities and is contraindicated during pregnancy. In the United States, all patients must enroll in iPLEDGE. Those who can become pregnant must follow its prevention plan—2 accepted contraceptive methods or continuous abstinence from sexual contact that could cause pregnancy—from 1 month before treatment through treatment and 1 month afterward. Pregnancy testing is required before starting, during treatment, at completion, and 1 month afterward, along with compliance with the applicable dispensing window.
According to the U.S. Food and Drug Administration (FDA), as of October 27, 2026, implementation of the changes approved in February is planned for November 15. Meanwhile, FDA allows certain pregnancy-testing flexibilities during and after treatment under prescriber supervision; pretreatment tests must be completed in a medical setting. The care team should confirm the current requirements for each patient.
Mental health is part of follow-up. A meta-analysis published in 2024, covering about 1.6 million participants, found no increased risk of suicide or psychiatric conditions at the population level. Its limitations and the possibility of individual reactions support reviewing mental health history and monitoring mood. New depressive symptoms, substantial behavioral changes, or thoughts of self-harm require stopping treatment and seeking immediate assessment.
Avoid some combinations: isotretinoin with doxycycline or other tetracyclines because of intracranial hypertension risk, and with vitamin A supplements because of additive toxicity. The prescriber should coordinate the switch between treatments. Follow your formulation’s food instructions because absorption varies by product. Do not share the medication or donate blood during treatment and for the following month. The prescribing information details these precautions.
Dry lips and skin are common and deserve a moisturizing plan. Severe headache with visual changes, severe abdominal pain, rectal bleeding, or a possible pregnancy requires immediate attention. A diary can track dryness, mood, medications, and supplements alongside lesions; dosing adjustments belong with the treating team.
Scientific sources
These sources support the information in this article and are available for readers who would like to explore the topic further.
Key readings
- Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1–1006.e30.
- Eichenfield DZ, Sprague J, Eichenfield LF. Management of Acne Vulgaris: A Review. JAMA. 2021;326(20):2055–2067.
- Layton AM, Bettoli V, Delore V, et al. The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review. Am J Clin Dermatol. 2026;27:17–47. Published online in 2025. Manuscript development and open access were supported by Sanofi.
Additional scientific sources
- Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10:5754.
- Zaenglein AL. Acne Vulgaris. N Engl J Med. 2018;379:1343–1352.
- Choi JM, Lew VK, Kimball AB. A single-blinded, randomized, controlled clinical trial evaluating the effect of face washing on acne vulgaris. Pediatr Dermatol. 2006;23(5):421–427.
- Galderma Laboratories. Differin: adapalene gel 0.1%. Drug Facts and patient leaflet. Drug labeling available through DailyMed. Accessed October 27, 2026.
- Galderma Laboratories. Differin Epiduo: adapalene 0.1% and benzoyl peroxide 2.5% gel. Drug Facts and patient leaflet. Over-the-counter drug labeling available through DailyMed. Accessed October 27, 2026.
- Adapalene and benzoyl peroxide gel 0.1%/2.5%: prescribing information. Drug labeling available through DailyMed. Revised February 2022.
- Smith RN, Mann NJ, Braue A, et al. A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr. 2007;86(1):107–115.
- Baldwin H, Tan J. Effects of Diet on Acne and Its Response to Treatment. Am J Clin Dermatol. 2021;22:55–65.
- He J, Ning N, He S, et al. Association of lifestyles and mental health with adult acne: A population-based cross-sectional study. J Eur Acad Dermatol Venereol. 2026;40:1258–1269.
- Donnarumma M, Fattore D, Greco V, et al. How to Increase Adherence and Compliance in Acne Treatment? A Combined Strategy of SMS and Visual Instruction Leaflet. Dermatology. 2019;235(6):463–470.
- Moore A, Ling M, Bucko A, et al. Efficacy and Safety of Subantimicrobial Dose, Modified-Release Doxycycline 40 mg Versus Doxycycline 100 mg Versus Placebo for the Treatment of Inflammatory Lesions in Moderate and Severe Acne: A Randomized, Double-Blinded, Controlled Study. J Drugs Dermatol. 2015;14(6):581–586.
- Doxycycline monohydrate capsules: prescribing information. Drug labeling available through DailyMed. Updated July 25, 2025.
- Doxycycline hyclate tablets and capsules: prescribing information. Drug labeling available through DailyMed. Revised April 2025.
- Nast A, Al Wattar BH, Beylot Barry M, et al. Update of the EuroGuiDerm evidence-based guideline for the treatment of acne—Short version. J Eur Acad Dermatol Venereol. 2026;40:1162–1172.
- Lai J, Barbieri JS. Acne Relapse and Isotretinoin Retrial in Patients With Acne. JAMA Dermatol. 2025;161(4):367–374.
- Xia E, Han J, Faletsky A, et al. Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study. JAMA Dermatol. 2022;158(8):942–948.
- Tan NKW, Tang A, MacAlevey NCYL, et al. Risk of Suicide and Psychiatric Disorders Among Isotretinoin Users: A Meta-Analysis. JAMA Dermatol. 2024;160(1):54–62.
- Isotretinoin capsules: prescribing information. Drug labeling available through DailyMed. Revised August 2026. Accessed October 27, 2026.
- U.S. Food and Drug Administration. iPLEDGE Risk Evaluation and Mitigation Strategy (REMS). February and June 2026 updates. Accessed October 27, 2026.
Discover more from Dr. Dándote Salud
Subscribe to get the latest posts sent to your email.
